You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 00713-0682


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00713-0682

Drug Name NDC Price/Unit ($) Unit Date
GENTAMICIN 0.1% OINTMENT 00713-0682-15 0.80927 GM 2024-12-18
GENTAMICIN 0.1% OINTMENT 00713-0682-31 0.87070 GM 2024-12-18
GENTAMICIN 0.1% OINTMENT 00713-0682-15 0.62018 GM 2024-11-20
GENTAMICIN 0.1% OINTMENT 00713-0682-31 0.87377 GM 2024-11-20
GENTAMICIN 0.1% OINTMENT 00713-0682-15 1.20986 GM 2024-10-23
GENTAMICIN 0.1% OINTMENT 00713-0682-31 0.89423 GM 2024-10-23
GENTAMICIN 0.1% OINTMENT 00713-0682-15 1.00133 GM 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 00713-0682

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
GENTAMICIN SO4 0.1% OINT,TOP Cosette Pharmaceutical, Inc. 00713-0682-15 15GM 27.26 1.81733 2020-08-15 - 2025-08-14 FSS
GENTAMICIN SO4 0.1% OINT,TOP Cosette Pharmaceutical, Inc. 00713-0682-31 30GM 51.45 1.71500 2020-08-15 - 2025-08-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

00713-0682 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 00713-0682

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number assigned to each drug product. It identifies the labeler, the specific product, and the trade package size[1][5].

Identifying the Drug

The NDC 00713-0682 can be broken down as follows:

  • Labeler Code: 00713
  • Product Code: 0682
  • Package Code: This varies based on the configuration (e.g., 4-4-2, 5-3-2, or 5-4-1)[5].

To proceed with the analysis, we need to identify the drug associated with this NDC. However, without specific details on the drug name, we will focus on general trends and factors influencing drug prices and market projections.

Market Trends in the Pharmaceutical Industry

Specialty Pharmaceuticals

Specialty pharmaceuticals, which include drugs for complex or chronic conditions such as cancer, autoimmune diseases, and pulmonary conditions, are a significant driver of drug price inflation. Vizient projects a 3.8% increase in drug prices, largely driven by specialty pharmaceuticals, including weight loss drugs and gene therapies[2].

Biosimilars

Biosimilars, which are biologic products that are highly similar to and have no clinically meaningful differences from an existing FDA-approved reference product, are expected to grow in market share. While they are anticipated to increase in price by only 0.55%, they will play a crucial role in managing pharmacy expenditures, especially as they gain market share against originator products like Humira[2].

Biopharma and Biotech Growth

The biopharma and biotech industries are experiencing rapid growth, driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. The biopharma market is projected to grow at a CAGR of 7.56% between 2024 and 2029, while the biotech sector is expected to grow at a CAGR of 9.4% between 2021 and 2027[3].

Price Projections

General Trends

  • Specialty Drugs: These drugs are expected to see a price increase of 4.18% in 2024, driven by their high cost and increasing utilization[2].
  • Biosimilars: While biosimilars are expected to increase in price by only 0.55%, they will help in reducing the overall cost burden by providing cheaper alternatives to originator biologics[2].

Specific Market Segments

  • Non-Small Cell Lung Cancer (NSCLC) Market: In the NSCLC market, drugs like Tagrisso, Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025. Tagrisso, for example, is expected to achieve $1.7 billion in sales by 2025, with a CAGR of 56.6% over the forecast period[4].

Factors Influencing Drug Prices

Regulatory Landscape

The regulatory landscape is evolving to keep pace with innovation. This includes accelerated clinical trial designs and a focus on precision medicine, which can impact the speed and cost of drug development[3].

Patent Expirations

Patent expirations of blockbuster drugs can significantly impact market dynamics. For instance, the patent expiration of drugs like Tarceva and Alimta will lead to a decrease in their sales and an increase in generic sales, affecting overall market growth[4].

Technological Advancements

Technological advancements, including AI and machine learning, are reshaping drug development and clinical trials. These innovations can lead to more efficient and cost-effective drug development processes[3].

Key Takeaways

  • Specialty Pharmaceuticals: These are driving drug price inflation and will continue to be a significant factor in market projections.
  • Biosimilars: Expected to grow in market share and help manage pharmacy expenditures.
  • Biopharma and Biotech Growth: Rapid growth driven by technological advancements and evolving regulatory frameworks.
  • Specific Market Segments: Drugs in the NSCLC market, such as Tagrisso and Keytruda, are projected to achieve significant sales by 2025.
  • Regulatory and Technological Factors: Evolving regulatory landscapes and technological advancements will continue to shape the pharmaceutical industry.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product[1][5].
  2. How are drug prices projected to change in 2024?

    • Drug prices are projected to increase by 3.8%, driven largely by specialty pharmaceuticals[2].
  3. What role will biosimilars play in the pharmaceutical market?

    • Biosimilars are expected to grow in market share and help reduce the cost burden by providing cheaper alternatives to originator biologics[2].
  4. How is the biopharma market expected to grow?

    • The biopharma market is projected to grow at a CAGR of 7.56% between 2024 and 2029[3].
  5. What are the key drivers of the NSCLC market growth?

    • The NSCLC market growth is driven by the increasing incorporation of premium-priced immune checkpoint inhibitor immunotherapies and targeted therapies like Tagrisso[4].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals - Vizient, Inc.
  3. 5 Predictions for the Biopharma and Biotech Industries in 2025 - TFS CRO
  4. NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - Drug Development
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.